Ubs Asset Management Americas Inc Neogenomics Inc Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 603,216 shares of NEO stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

603,216

Previous 626,455 3.71%

Holding current value

$10.2 Million

Previous $8.69 Million 2.41%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$13.4 - $17.73 $311,402 - $412,027	-23,239 Reduced 3.71%	603,216 $8.9 Million
Q2 2024 Aug 13, 2024	BUY	$13.01 - $15.77 $2.67 Million - $3.24 Million	205,436 Added 48.79%	626,455 $8.69 Million
Q1 2024 May 15, 2024	BUY	$14.06 - $16.79 $242,774 - $289,912	17,267 Added 4.28%	421,019 $6.62 Million
Q4 2023 Feb 14, 2024	SELL	$11.67 - $20.73 $160,275 - $284,705	-13,734 Reduced 3.29%	403,752 $6.53 Million
Q3 2023 Nov 13, 2023	BUY	$12.15 - $17.85 $267,555 - $393,074	22,021 Added 5.57%	417,486 $5.14 Million
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $3.59 Million - $7.69 Million	395,465 New	395,465 $6.89 Million
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $260,999 - $428,689	-33,206 Reduced 8.08%	377,967 $3.25 Million
Q2 2022 Aug 12, 2022	SELL	$7.06 - $13.97 $93,537 - $185,088	-13,249 Reduced 3.12%	411,173 $3.35 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $62,208 - $180,633	-5,120 Reduced 1.19%	424,422 $5.16 Million
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $260,811 - $414,783	-8,554 Reduced 1.95%	429,542 $14.7 Million
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $429,306 - $541,218	-10,305 Reduced 2.3%	438,096 $21.1 Million
Q2 2021 Aug 16, 2021	SELL	$36.62 - $51.69 $433,580 - $612,009	-11,840 Reduced 2.57%	448,401 $20.3 Million
Q1 2021 May 14, 2021	BUY	$41.56 - $59.88 $214,823 - $309,519	5,169 Added 1.14%	460,241 $22.2 Million
Q4 2020 Mar 01, 2021	SELL	$36.08 - $56.47 $465,071 - $727,898	-12,890 Reduced 2.75%	455,072 $24.5 Million
Q3 2020 Nov 13, 2020	BUY	$33.26 - $40.48 $81,753 - $99,499	2,458 Added 0.53%	467,962 $17.3 Million
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $441,977 - $566,301	18,256 Added 4.08%	465,504 $14.4 Million
Q1 2020 May 15, 2020	BUY	$20.5 - $34.53 $7.19 Million - $12.1 Million	350,722 Added 363.34%	447,248 $12.3 Million
Q4 2019 Feb 14, 2020	BUY	$18.96 - $29.84 $71,858 - $113,093	3,790 Added 4.09%	96,526 $2.82 Million
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $373,031 - $511,942	19,510 Added 26.64%	92,736 $1.77 Million
Q2 2019 Aug 15, 2019	BUY	$19.57 - $24.1 $167,303 - $206,030	8,549 Added 13.22%	73,226 $0
Q1 2019 May 14, 2019	BUY	$12.14 - $20.46 $98,309 - $165,685	8,098 Added 14.31%	64,677 $0
Q4 2018 Feb 13, 2019	BUY	$11.24 - $18.5 $367,311 - $604,561	32,679 Added 136.73%	56,579 $713,000
Q2 2018 Aug 14, 2018	BUY	$7.99 - $14.05 $190,961 - $335,795	23,900 New	23,900 $0

Others Institutions Holding NEO

# of Institutions

294

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.12B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Neogenomics Inc Transaction History